These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6446256)

  • 1. Chemical pathology of Huntington's disease.
    Bird ED
    Annu Rev Pharmacol Toxicol; 1980; 20():533-51. PubMed ID: 6446256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
    Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
    Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical findings in Huntington's chorea.
    Bird ED; Iversen LL
    Essays Neurochem Neuropharmacol; 1977; 1():177-95. PubMed ID: 152197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington's disease: genetics, chemical pathology, and management.
    Myers RH; Schoenfeld M; Bird ED
    Prog Med Genet; 1985; 6():91-122. PubMed ID: 2873625
    [No Abstract]   [Full Text] [Related]  

  • 5. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL; Waldvogel HJ; Glass M; Faull RL
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huntington's disease: new approaches to an old problem. The Robert Wartenberg lecture.
    Martin JB
    Neurology; 1984 Aug; 34(8):1059-72. PubMed ID: 6146951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntington's chorea. Changes in neurotransmitter receptors in the brain.
    Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH
    N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid.
    Beal MF; Kowall NW; Ellison DW; Mazurek MF; Swartz KJ; Martin JB
    Nature; 1986 May 8-14; 321(6066):168-71. PubMed ID: 2422561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical aspects of Huntington's disease].
    Bonilla E
    Acta Cient Venez; 1977; 28(6):391-7. PubMed ID: 24971
    [No Abstract]   [Full Text] [Related]  

  • 10. The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex.
    Storey E; Kowall NW; Finn SF; Mazurek MF; Beal MF
    Ann Neurol; 1992 Oct; 32(4):526-34. PubMed ID: 1280937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobiology and pharmacology of Huntington's disease.
    Enna SJ
    Life Sci; 1977 Jan; 20(2):205-11. PubMed ID: 190505
    [No Abstract]   [Full Text] [Related]  

  • 12. Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males.
    Bode FJ; Stephan M; Suhling H; Pabst R; Straub RH; Raber KA; Bonin M; Nguyen HP; Riess O; Bauer A; Sjoberg C; Petersén A; von Hörsten S
    Hum Mol Genet; 2008 Sep; 17(17):2595-609. PubMed ID: 18502785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scientific approaches to Huntington's disease.
    Sanberg PR; Coyle JT
    CRC Crit Rev Clin Neurobiol; 1984; 1(1):1-44. PubMed ID: 6100835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropharmacologic approach in Huntington's chorea].
    Agid Y
    Rev Neurol (Paris); 1975 Dec; 131(12):847-65. PubMed ID: 134438
    [No Abstract]   [Full Text] [Related]  

  • 15. [Huntington chorea. Review of the most recent aspects of research].
    Albano C; Farinini D; Tassinari T; Caponnetto C; Bacigalupo F
    Riv Neurol; 1985; 55(4):247-55. PubMed ID: 2997905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease: pathogenesis to animal models.
    Kumar P; Kalonia H; Kumar A
    Pharmacol Rep; 2010; 62(1):1-14. PubMed ID: 20360611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive tests in Huntington's disease.
    Paulson GW
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():317-29. PubMed ID: 137502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum.
    Kish SJ; Shannak K; Hornykiewicz O
    Ann Neurol; 1987 Sep; 22(3):386-9. PubMed ID: 2445259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmortem studies of peptides in Alzheimer's disease and Huntington's disease.
    Rossor M; Emson P; Dawbarn D; Dockray G; Mountjoy C; Roth M
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():259-77. PubMed ID: 2425405
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue.
    Spokes EG
    Brain; 1980 Mar; 103(1):179-210. PubMed ID: 6102490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.